L. Thielemans

发表

Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

J. Borovička, A. Bredenoord, M. Fox, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

The Hepatocarcinoma Cell Line HepG2 Does Not Express a GHS-R1a-Type Ghrelin Receptor

J. Aerssens, W. Luyten, B. Coulie, 2007, Journal of receptor and signal transduction research.

Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy

Arturo E. Hernandez, B. Carlin, E. Bertini, 2021, Orphanet Journal of Rare Diseases.

Sequence, distribution and quantification of the motilin precursor in the cat

I. Depoortere, T. Peeters, Luo Xu, 2003, Peptides.

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Hinrich W. H. Göhlmann, M. Camilleri, W. Talloen, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The effects of NO synthase inhibitors on murine collagen‐induced arthritis do not support a role of NO in the protective effect of IFN‐γ

A. Billiau, L. Thielemans, K. Vermeire, 2000, Journal of leukocyte biology.

Desensitization of the Human Motilin Receptor by Motilides

Yaoquan Liu, T. Thijs, I. Depoortere, 2005, Journal of Pharmacology and Experimental Therapeutics.

Searching for the Answer to Irritable Bowel Syndrome in the Colonic Mucosa: SERTainty and UnSERTainty

J. Aerssens, R. Urrutia, L. Thielemans, 2007 .

Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum

T. Thijs, I. Depoortere, T. Peeters, 2003, Journal of Pharmacology and Experimental Therapeutics.

An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15

C. Blackstone, A. Durr, R. Schüle, 2022, BMC Neurology.

Inactivation of the Constitutively Active Ghrelin Receptor Attenuates Limbic Seizure Activity in Rodents

G. Collingridge, Z. Bortolotto, Y. Michotte, 2012, Neurotherapeutics.

Interaction of the growth hormone releasing peptides, ghrelin and GHRP-6, with the motilin receptor in the rabbit gastric antrum.

T. Thijs, I. Depoortere, P. Robberecht, 2003 .

Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients

Arturo E. Hernandez, L. Servais, A. D’Amico, 2020, Molecular therapy. Methods & clinical development.

Randomized clinical trial: a controlled pilot trial of the 5‐HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis

J. Tack, A. Rotondo, A. Meulemans, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Hinrich W. H. Göhlmann, M. Camilleri, H. Göhlmann, 2007, Gastroenterology.

Translational medicine in neuromuscular disorders: from academia to industry

L. Thielemans, B. Cowling, 2019, Disease Models & Mechanisms.

Demonstration of a functional motilin receptor in TE671 cells from human cerebellum

G. Assche, I. Depoortere, T. Peeters, 2001, Brain Research.

Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits

G. Assche, T. Thijs, I. Depoortere, 2001, Regulatory Peptides.

Mechanisms involved in the loss of excitatory post-stimulus responses by inflammation

T. Thijs, I. Depoortere, T. Peeters, 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy

J. Laporte, L. Thielemans, S. Buono, 2022, Disease models & mechanisms.

An integrated modelling methodology for estimating the prevalence of centronuclear myopathy

L. Servais, J. Dowling, V. Biancalana, 2018, Neuromuscular Disorders.

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

P. Malfertheiner, N. Shaheen, M. Ruth, 2015, Alimentary pharmacology & therapeutics.

The motilin pharmacophore in CHO cells expressing the human motilin receptor.

I. Depoortere, T. Peeters, J. Vanden Broeck, 2002, Biochemical and biophysical research communications.

CLINICAL-ALIMENTARY TRACT Alterations in Expression of p11 and SERT in Mucosal Biopsy Specimens of Patients With Irritable Bowel Syndrome

M. Camilleri, H. Göhlmann, T. Smyrk, 2007 .

Leveraging Natural History Data in One- and Two-Arm Hierarchical Bayesian Studies of Rare Disease Progression

Arturo E. Hernandez, B. Carlin, E. Bertini, 2021, Statistics in Biosciences.

Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients

Arturo E. Hernandez, L. Servais, J. Laporte, 2020, Molecular therapy. Methods & clinical development.

182 EFFECT OF M0002, A NOVEL V2 ANTAGONIST ON SODIUM LEVELS AND WEIGHT GAIN AFFECTED BY WATER ACCUMULATION IN CIRRHOTIC PATIENTS WITH ASCITES

F. Nevens, R. Kerstens, A. Meulemans, 2009 .

The rat lacks functional genes for motilin and the motilin receptor

J. Aerssens, I. Depoortere, B. Coulie, 2004 .